Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

In Rae Cho

Showing results (61-70 of 104) with videos related to

Pageof 11
Sort By:
Gut and Liver|December 13, 2022
Combinatorial Effect of Prophylactic Interventions for Post-ERCP Pancreatitis among Patients with Risk Factors: A Network Meta-AnalysisJin Ho Choi, Sang Hyub Lee, Joo Seong Kim, et al.
Plos One|June 27, 2017
Clinical characteristics of second primary pancreatic cancerJung Hyun Jo, In Rae Cho, Jang Han Jung, et al.
World Journal of Gastroenterology|June 2, 2017
Benefit of neoadjuvant concurrent chemoradiotherapy for locally advanced perihilar cholangiocarcinomaJang Han Jung, Hyun Jik Lee, Hee Seung Lee, et al.
Urology|December 26, 2007
Age-specific prostate-specific antigen reference ranges in Korean menYoung Deuk Choi, Dae Ryong Kang, Chung Mo Nam, et al.
World Journal of Gastrointestinal Oncology|February 28, 2020
FOLFIRINOX <i>vs</i> gemcitabine/nab-paclitaxel for treatment of metastatic pancreatic cancer: Single-center cohort studyIn Rae Cho, Huapyong Kang, Jung Hyun Jo, et al.
Urology|February 8, 2006
Detection rate of prostate cancer on biopsy according to serum prostate-specific antigen in Korean men: a multicenter studyWon Jae Yang, Dong Hyeon Lee, Byung Ha Chung, et al.
Urology|June 6, 2008
Prostate-specific antigen velocity in healthy Korean men with initial PSA levels of 4.0 ng/mL or lessWon Sik Ham, Dae Ryong Kang, Young Sig Kim, et al.
Yonsei Medical Journal|June 27, 2008
A comprehensive prognostic stratification for patients with metastatic renal clear cell carcinomaKang Su Cho, Young Deuk Choi, Se Joong Kim, et al.
Oncology|May 7, 2026
Treatment Outcomes in Frail Patients with Advanced Pancreatic Ductal Adenocarcinoma: A Real-World Comparison of Gemcitabine, S-1, and Stereotactic Ablative RadiotherapyChang Hyun Kim, Eun Jeong Kim, Tae Seung Lee, et al.
Yonsei Medical Journal|May 27, 2026
SpyGlass Direct Visualization System: A Cost-Effective Approach Enhancing Nutritional and Immune Recovery in Difficult Bile Duct Stone ManagementKyung In Shin, Galam Leem, Jungchul Koo, et al.
Pageof 11

Showing results (61-70 of 104) with videos related to

Sort By:
Pageof 11
Gut and Liver|December 13, 2022
Combinatorial Effect of Prophylactic Interventions for Post-ERCP Pancreatitis among Patients with Risk Factors: A Network Meta-AnalysisJin Ho Choi, Sang Hyub Lee, Joo Seong Kim, et al.
Plos One|June 27, 2017
Clinical characteristics of second primary pancreatic cancerJung Hyun Jo, In Rae Cho, Jang Han Jung, et al.
World Journal of Gastroenterology|June 2, 2017
Benefit of neoadjuvant concurrent chemoradiotherapy for locally advanced perihilar cholangiocarcinomaJang Han Jung, Hyun Jik Lee, Hee Seung Lee, et al.
Urology|December 26, 2007
Age-specific prostate-specific antigen reference ranges in Korean menYoung Deuk Choi, Dae Ryong Kang, Chung Mo Nam, et al.
World Journal of Gastrointestinal Oncology|February 28, 2020
FOLFIRINOX <i>vs</i> gemcitabine/nab-paclitaxel for treatment of metastatic pancreatic cancer: Single-center cohort studyIn Rae Cho, Huapyong Kang, Jung Hyun Jo, et al.
Urology|February 8, 2006
Detection rate of prostate cancer on biopsy according to serum prostate-specific antigen in Korean men: a multicenter studyWon Jae Yang, Dong Hyeon Lee, Byung Ha Chung, et al.
Urology|June 6, 2008
Prostate-specific antigen velocity in healthy Korean men with initial PSA levels of 4.0 ng/mL or lessWon Sik Ham, Dae Ryong Kang, Young Sig Kim, et al.
Yonsei Medical Journal|June 27, 2008
A comprehensive prognostic stratification for patients with metastatic renal clear cell carcinomaKang Su Cho, Young Deuk Choi, Se Joong Kim, et al.
Oncology|May 7, 2026
Treatment Outcomes in Frail Patients with Advanced Pancreatic Ductal Adenocarcinoma: A Real-World Comparison of Gemcitabine, S-1, and Stereotactic Ablative RadiotherapyChang Hyun Kim, Eun Jeong Kim, Tae Seung Lee, et al.
Yonsei Medical Journal|May 27, 2026
SpyGlass Direct Visualization System: A Cost-Effective Approach Enhancing Nutritional and Immune Recovery in Difficult Bile Duct Stone ManagementKyung In Shin, Galam Leem, Jungchul Koo, et al.
Pageof 11